Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • SEATTLE GENETICS INC Analyst Recommendations

  • Analyst Consensus: SGEN

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 1.889 Buy 9
    30 Days Ago 1.750 Buy 8
    60 Days Ago 1.750 Buy 8
    90 Days Ago 1.714 Buy 7
    120 Days Ago 1.714 Buy 7

  • Analyst Ratings: SGEN

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    Leerink Swann — Mkt Perform 10/15/2009 12.00
    Deutsche Securities — Buy 08/12/2009 14.00
    Oppenheimer Perform Outperform 10/27/2008 12.00
    Stanford Research — Hold 10/07/2008 —
    UBS — Neutral 07/23/2008 11.00
    UBS — Neutral 06/19/2008 —
    Banc of America Sec — Neutral 04/30/2008 12.00
    RBC Capital Mkts Sector Perform Outperform 03/19/2008 —
    Caris & Company Buy — 03/13/2008 —
    JP Morgan — Overweight 01/28/2008 —
    Needham & Co — Buy 10/24/2007 15.00
    Caris & Company — Buy 10/24/2007 13.00
    RBC Capital Mkts Outperform Sector Perform 10/15/2007 —
    Fortis Bank — Buy 09/21/2007 —
    William Blair — Outperform 08/21/2007 —
    Caris & Company — Buy 07/26/2007 11.00
    Needham & Co — Buy 04/25/2007 12.00
    RBC Capital Mkts — Outperform 04/25/2007 12.00
    Caris & Company — Buy 03/08/2007 —
    Next Generation — Buy 01/16/2007 10.00
    RBC Capital Mkts Sector Perform Outperform 01/09/2007 9.00
    Needham & Co — Buy 01/09/2007 10.00
    Banc of America Sec — Buy 12/12/2006 9.00
    Needham & Co — Buy 10/25/2006 8.00
    Next Generation — Buy 10/05/2006 6.00
    RBC Capital Mkts — Sector Perform 07/26/2006 6.00
    Banc of America Sec Neutral Buy 05/24/2006 —
    Susquehanna Financial Neutral Negative 02/09/2006 —
    Banc of America Sec — Neutral 11/29/2005 6.00
    Needham & Co — Buy 10/17/2005 7.00
    Next